ArticleIET nanobiotechnology2021

Enhancement of in vitro antitumour activity of epirubicin in HER2+ breast cancer cells using immunoliposome formulation.

Farnaz Khaleseh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.